NDC 53489-143 – Spironolactone
Spironolactone 25 mg/1 · Tablet · Oral
Product NDC53489-143
Product details
- Brand name
- Spironolactone
- Generic name
- Spironolactone
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA089424
- Marketed since
- July 23, 1986
- Marketing end
- February 28, 2029
- Pharmacologic class
- Aldosterone Antagonist
Active ingredients
- Spironolactone 25 mg/1
Uses, dosage, side effects and warnings for Spironolactone →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 53489-143-01 | 100 TABLET in 1 BOTTLE, PLASTIC (53489-143-01) | Jul 23, 1986 |
| 53489-143-05 | 500 TABLET in 1 BOTTLE, PLASTIC (53489-143-05) | Jul 23, 1986 |
| 53489-143-10 | 1000 TABLET in 1 BOTTLE, PLASTIC (53489-143-10) | Jul 23, 1996 |
Recalls mentioning this NDC
- D-0574-2025 Aug 13, 2025 · Class II
Presence of foreign substance: identified as aluminum.
Other Spironolactone products
- 50090-7083 Spironolactone 50 mg/1 · Tablet · A-S Medication Solutions
- 50090-0136 Spironolactone 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-6908 Spironolactone 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-6909 Spironolactone 25 mg/1 · Tablet · A-S Medication Solutions
- 50090-7082 Spironolactone 50 mg/1 · Tablet · A-S Medication Solutions
- 60687-465 Spironolactone 25 mg/1 · Tablet · American Health Packaging
- 60687-476 Spironolactone 50 mg/1 · Tablet · American Health Packaging
- 60687-487 Spironolactone 100 mg/1 · Tablet · American Health Packaging
- 65162-511 Spironolactone 25 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 65162-514 Spironolactone 50 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 65162-515 Spironolactone 100 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 53746-515 Spironolactone 100 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC